Analyst upgrades 5-25-07: GSK, LNVGY, RFMD and TWB
Posted May 25th 2007 11:01AM by Kevin Shult
Filed under: Before the Bell, Analyst Upgrades and Downgrades, Good news
MOST NOTEWORTHY: GlaxoSmithKline plc (GSK), RF Micro Devices, Inc (RFMD), BMC Software, Inc (BMC) and Tween Brands Inc (TWB) were today's noteworthy upgrades:
- GlaxoSmithKline (NYSE: GSK) was upgraded to Hold from Sell at Societe General on valuation.
- Jefferies upgraded shares of RF Micro Devices (NASDAQ: RFMD) to Buy from Hold and raised the target to $9.00 from $7.00 after their channel checks indicated RFMD's business has improved since its last earnings call.
- Cowen raised BMC Software (NYSE: BMC) to Neutral from Underperform citing valuation and improvements in the cash flow for their upgrade.
- Susquehanna upgraded Tween Brands (NYSE: TWB) to Positive from Neutral based on Justice's performance and recent buyback activity...
OTHER UPGRADES:
- Lenovo Group Ltd (OTC: LNVGY) was upgraded at Credit Suisse to Neutral from Underperform; JP Morgan upgraded Lenovo to Overweight from Neutral.
- Goldman upgraded CDI Corp (NYSE: CDI) to Buy from Neutral.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Tags: analyst, bmc, cdi, glaxo, gsk, lenovo, linux, lnvgy, lunx, mdth, medcath, micro, rating, rfmd, symm, symmetricom, theflyonthewall.com, twb, tween, upgrade, va software, VaSoftware
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
